Evotec SE EVO

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $1.96
Market Cap $714.33M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-7.2% YoY
$788.37M
3-Yr CAGR: 1.6%
Net Income ↑55.3% YoY
-$86.77M
Net Margin: -11.0%
Free Cash Flow ↑36.8% YoY
-$77.97M
FCF Yield: -10.91%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-10.7%
ROA: -5.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (EVO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $446.4M $132.9M $56.7M
FY 2020 $500.9M +12.2% $125.7M $25.8M -54.4% $1.2M $-97.9M
FY 2021 $618.0M +23.4% $151.5M $237.0M +817.1% $1.1M $-117.8M -20.4%
FY 2022 $751.4M +21.6% $174.1M $-154.0M -165.0% $3.0M $-178.3M -51.3%
FY 2023 $781.4M +4.0% $175.1M $-80.6M +47.7% $-12.9M $-226.2M -26.8%
FY 2024 $849.7M +8.7% $114.9M $-194.0M -140.7% $-5.9M $-123.4M +45.4%
FY 2025 $788.4M -7.2% $114.2M $-86.8M +55.3% $-5.4M $-78.0M +36.8%
$

Valuation

Market Price $1.96
Market Cap $714.33M
Enterprise Value $743.50M
P/E Ratio N/A
P/B Ratio 0.86
FCF Yield -10.91%
Dividend Yield N/A
Shares Outstanding 355,389,108
%

Profitability & Margins

Gross Margin 14.49%
Operating Margin -2.38%
Net Margin -11.01%
Return on Equity (ROE) -10.66%
Return on Assets (ROA) -5.06%
Asset Turnover 0.46x
Revenue 3-Yr CAGR 1.61%
🛡️

Financial Health & Liquidity

Current Ratio 35.65
Cash Ratio 19.56
Debt / Equity 0.550
Debt / Assets 0.261
Cash & Equivalents $418.52M
Total Debt $447.69M
Book Value / Share $2.29
💧

Cash Flow Efficiency

Operating Cash Flow -$5.42M
Capital Expenditures (CapEx) $72.54M
Free Cash Flow -$77.97M
OCF / Revenue -0.69%
FCF / Revenue -9.89%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $2.29
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.71B
Total Liabilities $1.71B
Stockholders' Equity $813.70M
Current Assets $762.95M
Current Liabilities $21.40M